Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 18 04:00PM ET
305.99
Dollar change
+2.71
Percentage change
0.89
%
IndexDJIA, NDX, S&P 500 P/E43.76 EPS (ttm)6.99 Insider Own0.23% Shs Outstand535.40M Perf Week1.76%
Market Cap164.14B Forward P/E14.79 EPS next Y20.69 Insider Trans-0.17% Shs Float535.19M Perf Month-2.07%
Income3.76B PEG7.99 EPS next Q4.97 Inst Own78.19% Short Float1.69% Perf Quarter12.61%
Sales29.35B P/S5.59 EPS this Y4.40% Inst Trans-1.47% Short Ratio3.66 Perf Half Y11.09%
Book/sh9.36 P/B32.68 EPS next Y6.27% ROA4.14% Short Interest9.05M Perf Year33.24%
Cash/sh18.10 P/C16.91 EPS next 5Y5.47% ROE72.57% 52W Range218.44 - 329.72 Perf YTD6.24%
Dividend Est.9.26 (3.03%) P/FCF23.13 EPS past 5Y-0.22% ROI5.78% 52W High-7.20% Beta0.57
Dividend TTM8.76 (2.86%) Quick Ratio0.98 Sales past 5Y3.42% Gross Margin66.17% 52W Low40.08% ATR (14)5.75
Dividend Ex-DateMay 16, 2024 Current Ratio1.42 EPS Y/Y TTM-52.50% Oper. Margin24.84% RSI (14)55.97 Volatility1.61% 1.65%
Employees26700 Debt/Eq12.75 Sales Y/Y TTM13.18% Profit Margin12.82% Recom2.21 Target Price317.30
Option/ShortYes / Yes LT Debt/Eq11.96 EPS Q/Q-103.99% Payout68.24% Rel Volume0.87 Prev Close303.28
Sales Surprise-0.06% EPS Surprise2.09% Sales Q/Q22.19% EarningsMay 02 AMC Avg Volume2.47M Price305.99
SMA200.42% SMA504.53% SMA2008.25% Trades Volume2,162,723 Change0.89%
Date Action Analyst Rating Change Price Target Change
May-03-24Upgrade William Blair Mkt Perform → Outperform
May-03-24Upgrade Barclays Underweight → Equal Weight $230 → $300
Mar-28-24Resumed Raymond James Mkt Perform
Feb-07-24Downgrade Leerink Partners Outperform → Market Perform $324 → $318
Dec-21-23Upgrade Daiwa Securities Neutral → Buy $264 → $320
Dec-19-23Upgrade BMO Capital Markets Market Perform → Outperform $286 → $326
Dec-12-23Upgrade RBC Capital Mkts Sector Perform → Outperform $256 → $300
Nov-09-23Initiated Deutsche Bank Hold $240
Nov-02-23Upgrade Truist Hold → Buy $260 → $320
Oct-20-23Resumed JP Morgan Neutral $265 → $270
Jun-18-24 09:00AM
Jun-17-24 03:27PM
09:54AM
08:00AM
04:32AM
06:45PM Loading…
Jun-14-24 06:45PM
04:21PM
Jun-13-24 05:50PM
08:00AM
Jun-12-24 09:00AM
03:29AM
Jun-11-24 09:39AM
Jun-09-24 09:00AM
Jun-07-24 05:50PM
09:00AM
11:59AM Loading…
Jun-06-24 11:59AM
06:26AM
Jun-05-24 04:00PM
03:26PM
09:00AM
Jun-03-24 04:00PM
09:00AM
08:00AM
May-31-24 12:20PM
12:18PM
May-29-24 02:51PM
08:15AM
04:25AM
May-28-24 05:56PM
04:48PM
11:32AM Loading…
11:32AM
09:00AM
May-27-24 09:00AM
03:02AM
May-26-24 06:53AM
May-25-24 11:15PM
11:10PM
May-24-24 12:16PM
07:00AM
May-22-24 05:17PM
05:41AM
May-21-24 09:44AM
May-20-24 04:38PM
01:34PM
08:00AM
07:48AM
06:47AM
May-19-24 05:15PM
06:15AM
May-17-24 03:02PM
11:47AM
08:24AM
08:06AM
04:31AM
May-16-24 06:46PM
04:16PM
09:00AM
03:01AM
May-15-24 06:45PM
01:28PM
11:14AM
07:01AM
May-13-24 11:00AM
05:53AM
May-12-24 09:15AM
May-10-24 05:14PM
03:17PM
May-09-24 04:17PM
04:00PM
10:34AM
08:12AM
07:00AM
06:44AM
May-08-24 02:13PM
01:22PM
01:12PM
May-07-24 03:28PM
02:50PM
09:00AM
May-06-24 04:49PM
08:41AM
07:15AM
May-04-24 01:03AM
May-03-24 06:15PM
05:07PM
04:51PM
04:49PM
04:04PM
03:46PM
02:53PM
01:58PM
01:00PM
12:53PM
12:31PM
12:26PM
12:14PM
12:13PM
11:48AM
11:35AM
11:23AM
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Grygiel Nancy A.SVP & CCOMay 03 '24Sale313.092,117662,8029,883May 03 07:48 PM
Grygiel Nancy A.SVP & CCODec 04 '23Sale273.032,096572,27610,874Dec 04 07:41 PM
Graham Jonathan PEVP, Gen. Counsel & Secy.Nov 08 '23Sale272.8110,0002,728,13628,078Nov 13 08:30 PM
AMGEN INC10% OwnerSep 19 '23Buy17.001,764,70529,999,98535,368,653Sep 19 07:52 PM
Gordon MurdoEVP, Global Commercial OpsAug 10 '23Sale262.439,5582,508,30644,308Aug 11 06:13 PM